Dawn Halkuff, Director at Xeris Biopharma Holdings, Inc. (XERS), bought 5,410 shares at $1.84 ($10K) on 2023-11-20, disclosed to the SEC on 2023-11-21.
Open-market purchase of $10k XERS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |